SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

Correspondence Activity Detail

VERTEX PHARMACEUTICALS INC / MA (VRTX) (CIK 0000875320) (VRTX)
Activity window: Nov. 12, 2025 to Nov. 11, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
3.5 / 10
Correspondence-letter component
2.0
AI sentiment component
1.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Nov. 11, 2026. Latest filing activity: Apr. 14, 2026. These dates describe different events.

Correspondence Filings
2
Keyword Matches
0
Latest Activity
Apr. 14, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 14, 2026 UPLOAD Neutral/Informational Low The SEC has completed its review of Vertex Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2025. They remind the company that it is ultimately responsible for th… Read Filing EDGAR
Apr. 1, 2026 CORRESP Neutral/Informational Low Vertex Pharmaceuticals submitted a response to the SEC's comment letter regarding their Form 10-K for the fiscal year ended December 31, 2025. The SEC requested additional disclos… Read Filing EDGAR
Mar. 18, 2026 UPLOAD Concern from SEC High The SEC has issued a comment letter to Vertex Pharmaceuticals regarding their Form 10-K for the fiscal year ended December 31, 2025. The letter specifically requests additional in… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.